Predictive factors for perioperative blood transfusions in laparoscopic colorectal surgery

International Journal of Colorectal Disease

Volumn 29, Issue 6, 2014, Pages 723-728

  Abu Ghanem, Yasmin ^a   Mahajna, Hussein ^a   Ghinea, Ronen ^a   White, Ian ^a   Inbar, Roy ^a   Avital, Shmuel ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b ASSUTA MEDICAL CENTER   (Israel)

Author keywords

Colorectal; Laparoscopy; Perioperative blood transfusions; Predictive factors

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD TRANSFUSION; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL SURGERY; COMORBIDITY; CONVERSION TO OPEN SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; PERIOPERATIVE BLOOD TRANSFUSION; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM SURGERY; SURGICAL RISK; ADOLESCENT; AGED; COLONIC DISEASES; COLORECTAL NEOPLASMS; LAPAROSCOPY; RECTAL DISEASES; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONIC DISEASES; COLORECTAL NEOPLASMS; COMORBIDITY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; RECTAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84921940726     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-014-1854-6     Document Type: Article

References (39)

1. Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49(8):1116-1130 (Pubitemid 44221295)
2. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P (2001) Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery 129(4):433-439 (Pubitemid 32289893)
3. Amato A, Pescatori M (2011) Perioperative blood transfusions and recurrence of colorectal cancer (review) no. 2
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334(26):1685-1690 (Pubitemid 26193619)
5. Ghinea R, Greenberg I, White E, Sacham-Shmueli H, Mahagna, S. Avital (2013) Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival. Tech Coloproctol
6. Tartter PI (1988) Blood transfusion and infectious complications following colorectal cancer surgery. Brit J Surg 75(8):789-792
7. Wobbes T, Bemelmans BL, Kuypers JH, Beerthuizen GI, Theeuwes AG (1990) Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet 171(1):59-62 (Pubitemid 20223199)
8. Edna TH, Bjerkeset T (1998) Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 41(4):451-459
9. Blumberg N, Agarwal MM, Chuang C (1985) Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (Clin Res Ed) 290(6474):1037-1039 (Pubitemid 15109947)
10. Burrows L, Tartter P (1982) Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 2(8299):662
11. Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 41(5):570-585 (Pubitemid 28224088)
12. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA (2013) The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63(5):839-845
13. Braga M, Vignali A, Gianotti L, Zuliani W, Radaelli G, Gruarin P, Dellabona P, Di Carlo V (2002) Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 236(6): 759-766, discussion 767
14. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW (1994) Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol Off J Am Soc Clin Oncol 12(9):1859-1867 (Pubitemid 24349388)
15. Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR (2005) How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 87(1):3-14 (Pubitemid 40104225)
16. Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M (2006) Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol 18(1):60-66 (Pubitemid 43056698)
17. Kim J, Konyalian V, Huynh R, Mittal R, Stamos M, Kumar R (2007) Identification of predictive factors for perioperative blood transfusion in colorectal resection patients. Int J Colorectal Dis 22(12):1493-1497 (Pubitemid 47543341)
18. Tang R, Wang JY, Chien CR, Chen JS, Lin SE, Fan HA (1993) The association between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer 72(2):341-348 (Pubitemid 23193436)
19. Sabalić S, Kovacević D, Glavić Z, Buković D, Despot A, Fajdić J, Lukac J, Seso I (2006) The immunomodulation effect of allogenic blood transfusion in colorectal cancer-a new approach. Coll Antropol 30(4):885-893
20. Gascón P, Zoumbos NC, Young NS (1984) Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 100(2):173-177 (Pubitemid 14188764)
21. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F (1999) Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93(5):1770-1777 (Pubitemid 29102506)
22. Kaplan J, Sarnaik S, Gitlin J, Lusher J (1984) Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 64(1):308-310 (Pubitemid 14083893)
23. Opelz G, Terasaki PI (1974) Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet 2(7882):696-698
24. Edna TH, Bjerkeset T (1992) Association between blood transfusion and infection in injured patients. J Trauma 33(5):659-661
25. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sørensen F, Hokland M (1992) Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 79(6):513-516
26. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB (2009) Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 208(5):931 -937, 937.e1 - 2; discussion 938 -9
27. Torchia MG, Danzinger RG (2000) Perioperative blood transfusion and albumin administration are independent risk factors for the development of postoperative infections after colorectal surgery. Can J Surg J Can Chir 43(3):212-216 (Pubitemid 30394801)
28. Moore FA, Moore EE, Sauaia A (1997) Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surgery (Chicago, Ill: 1960) 132(6):620-624, discussion 624-5
29. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54(5):898-905, discussion 905-7
30. Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1: CD005033
31. Busch OR, Hop WC, Marquet RL, Jeekel J (1994) Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 220(6):791-797 (Pubitemid 24376378)
32. Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G (2003) Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 237(3): 417-421 (Pubitemid 38176458)
33. Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R (2005) Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth J Can Anesth 52(4):362-368 (Pubitemid 40753820)
34. Kettelhack C, Hönes C, Messinger D, Schlag PM (1998) Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Bri J Surg 85(1):63-67 (Pubitemid 28034114)
35. Nursal TZ, Hamaloǧlu E (2006) The effect of preoperative blood transfusion on morbidity and survival in colorectal malignancy. Turk J Gastroenterol Off J Turk Soc Gastroenterol 17(4):283-287 (Pubitemid 351676933)
36. Carson JL (1998) Perioperative blood transfusion and postoperative mortality. JAMA 279(3):199
37. Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey JA (2003) Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 98(2): 337-342 (Pubitemid 36592799)
38. Gonçalves I, Linhares M, Bordin J, Matos D (2009) Artigo original/Original article. Risk factors for indications of among patients undergoing surgical treatment for colorectal adenocarcinoma. Arq Gastroenterol 3:190-193
39. Frank SM, Savage WJ, Rothschild JA, Rivers RJ, Ness PM, Paul SL, Ulatowski JA (2012) Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 117(1):99-106